DE HB62 | 2021-2022 | 151st General Assembly
Status
Spectrum: Moderate Partisan Bill (Democrat 18-2)
Status: Introduced on January 7 2021 - 25% progression, died in committee
Action: 2021-01-07 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]
Status: Introduced on January 7 2021 - 25% progression, died in committee
Action: 2021-01-07 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act is based on a Model Act to Prevent Excessive and Unconscionable Prices for Prescription Drugs developed by the National Academy for State Health Policy. It prohibits manufacturers from raising the price of prescription drugs outside of certain market conditions that might justify a price hike. It is specifically limited to the prices charged to consumers in the State of Delaware for generic and off-patent drugs.
Title
An Act To Amend Title 6 Of The Delaware Code Relating To The Prohibition Of Excessive And Unconscionable Prices For Prescription Drugs.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2021-01-07 | Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House |